Prenetics Global ($PRE) Q2 2026 Earnings Analysis — Revenue Misses Estimates but Shares Rebound After Hours on Raised Guidance
Earnings Scorecard
Revenue: $46.5 million (+288% YoY, estimate $49.18 million) ❌ Miss
EPS (Earnings Per Share): IFRS basic loss per share -$0.52 (Q2 2026), estimate -$0.48 (adjusted basis) — different bases, not directly comparable
Guidance: Raised — 2026 total revenue $220–230 million, newly introduced 2027 IM8 revenue of $400 million or more
Stock Reaction: After-hours +5.11% ($20.36) — as of 08-18 20:59 KST
Positives
IM8 Revenue Surge: Q2 2026 IM8 revenue of $45 million, up approximately +359% YoY
Full-Year and Next-Year Guidance: Raised 2026 total revenue guidance to $220–230 million and introduced 2027 IM8 revenue of $400 million or more
Cash Flow Inflection: Consolidated adjusted free cash flow turned positive for the first time in July 2026, with the company expecting this to continue from Q3 onward
The flagship brand IM8 reached an annualized run-rate revenue of approximately $251 million as of July, about 20 months after launch.
Negatives
Revenue Consensus Miss: Total revenue of $46.5 million fell short of the $49.18 million estimate
Growth Investment Costs: Sharp increase in Q2 sales and marketing expenses, adjusted EBITDA loss of $19 million
Cohort and Annualized Metrics: July results and annualized revenue are preliminary and sensitive to the billing cycle
Monthly and annualized metrics can temporarily inflate in months when quarterly billings are concentrated, and the company noted that it does not guarantee future revenue. Whether the long-term retention of recent large new customer cohorts matches that of past cohorts will need to be confirmed over the next several quarters of data.
What the Company Said
CEO Danny Yeung explained that the timing of consolidated adjusted free cash flow turning positive came earlier than planned before launch. He emphasized that revenue from upcoming new products has not been incorporated into guidance.
Market Reaction and Key Points Ahead
Revenue missed Wall Street estimates, but IM8 revenue coming in above guidance ($44–46M), the raised full-year outlook, and the cash flow inflection appear to have driven buying interest.
Whether Q3 total revenue guidance of $63–64 million is achieved
Whether the consolidated adjusted free cash flow positive streak continues
Retention trends of new large customer cohorts and customer acquisition cost trajectory
Disclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.